E. W. Gregg, Y. Li, and J. Wang, Changes in diabetes-related complications in the United States, N Engl J Med, vol.370, pp.1514-1523, 1990.

T. J. Orchard, A. M. Secrest, R. G. Miller, and T. Costacou, In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study, Diabetologia, vol.53, pp.2312-2319, 2010.

K. Mohammedi, S. Maimaitiming, and N. Emery, Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects, Mol Genet Metab, vol.104, pp.654-660, 2011.

T. A. Patente, K. Mohammedi, and N. Bellili-muñoz, Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes
URL : https://hal.archives-ouvertes.fr/hal-01933269

, Free Radic Biol Med, vol.86, pp.16-24, 2015.

N. Stefan and M. Stumvoll, Adiponectin--its role in metabolism and beyond, Horm Metab Res, vol.34, pp.469-474, 2002.

H. S. Randeva, M. Vatish, and B. K. Tan, Raised plasma adiponectin levels in type 1 diabetic pregnancies, Clin Endocrinol, vol.65, pp.17-21, 2006.

K. Heilman, M. Zilmer, K. Zilmer, P. Kool, and V. Tillmann, Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes, Scand J Clin Lab Invest, vol.69, pp.85-91, 2009.

E. Mannucci, A. Ognibene, and F. Cremasco, Plasma adiponectin and hyperglycaemia in diabetic patients, Clin Chem Lab Med, vol.41, pp.1131-1135, 2003.

S. Hadjadj, R. Aubert, and F. Fumeron, Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects, Diabetologia, vol.48, pp.1088-1092, 2005.

A. Jorsal, L. Tarnow, and J. Frystyk, Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy, Kidney Int, vol.74, pp.649-654, 2008.

N. Sweiss and K. Sharma, Adiponectin effects on the kidney, Best Pract Res Clin Endocrinol Metab, vol.28, pp.71-79, 2014.

H. C. Looker, J. Krakoff, and T. Funahashi, Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes, J Clin Endocrinol Metab, vol.89, pp.4010-4017, 2004.

L. Ortega-moreno, O. Lamacchia, and M. Copetti, Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes, PLoS One, vol.10, p.140631, 2015.

R. Jaziri, R. Aubert, and R. Roussel, Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes, Nephrol Dial Transplant, vol.25, pp.2231-2237, 2010.

N. Vionnet, D. Tregouët, and G. Kazeem, Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene, Diabetes, vol.55, pp.3166-3174, 2006.

T. Takeuchi, Y. Adachi, Y. Ohtsuki, and M. Furihata, Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease, Med Mol Morphol, vol.40, pp.115-120, 2007.

M. Philippova, M. B. Joshi, E. Kyriakakis, D. Pfaff, P. Erne et al., A guide and guard: the many faces of T-cadherin, Cell Signal, vol.21, pp.1035-1044, 2009.

D. B. Ivanov, M. P. Philippova, and V. A. Tkachuk, Structure and functions of classical cadherins, Biochemistry, vol.66, pp.1174-1186, 2001.

C. Hug, J. Wang, N. S. Ahmad, J. S. Bogan, T. Tsao et al., T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin, Proc Natl Acad Sci U S A, vol.101, pp.10308-10313, 2004.

M. S. Denzel, M. Scimia, P. M. Zumstein, K. Walsh, P. Ruiz-lozano et al., Tcadherin is critical for adiponectin-mediated cardioprotection in mice, J Clin Invest, vol.120, pp.4342-4352, 2010.

J. L. Parker-duffen, K. Nakamura, and M. Silver, T-cadherin is essential for adiponectinmediated revascularization, J Biol Chem, vol.288, pp.24886-24897, 2013.

E. Org, S. Eyheramendy, and P. Juhanson, Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations, Hum Mol Genet, vol.18, pp.2288-2296, 2009.

C. Chung, T. Lin, and J. Chen, A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes, Diabetes, vol.60, pp.2417-2423, 2011.

J. L. Parker-duffen and K. Walsh, Cardiometabolic effects of adiponectin, Best Pract Res Clin Endocrinol Metab, vol.28, pp.81-91, 2014.

S. Hadjadj, F. Péan, and Y. Gallois, Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study, Diabetes Care, vol.27, pp.2661-2669, 2004.

M. Marre, X. Jeunemaitre, and Y. Gallois, Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group, J Clin Invest, vol.99, pp.1585-1595, 1997.

S. Hadjadj, R. Belloum, and B. Bouhanick, Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study, J Am Soc Nephrol, vol.12, pp.541-549, 2001.

A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann Intern Med, vol.130, pp.461-470, 1999.

C. Fava, E. Danese, and M. Montagnana, A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes, Am J Cardiol, vol.108, pp.1432-1437, 2011.

D. A. Tregouet and V. Garelle, A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies, Bioinformatics, vol.23, pp.1038-1039, 2007.

C. G. Schalkwijk, N. Chaturvedi, M. T. Schram, J. H. Fuller, and C. Stehouwer, Adiponectin is inversely associated with renal function in type 1 diabetic patients, J Clin Endocrinol Metab, vol.91, pp.129-135, 2006.

M. Saraheimo, C. Forsblom, and J. Fagerudd, Serum adiponectin is increased in type 1 diabetic patients with nephropathy, Diabetes Care, vol.28, pp.1410-1414, 2005.

B. Kollerits, D. Fliser, I. M. Heid, E. Ritz, F. Kronenberg et al., Genderspecific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study, Kidney Int, vol.71, pp.1279-1286, 2007.

Y. Yano, S. Hoshide, and J. Ishikawa, Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes, J Clin Hypertens (Greenwich), vol.9, pp.775-782, 2007.

C. Menzaghi, D. Cosmo, S. Copetti, and M. , Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study, Diabetologia, vol.54, pp.812-818, 2011.

K. Sharma, S. Ramachandrarao, and G. Qiu, Adiponectin regulates albuminuria and podocyte function in mice, J Clin Invest, vol.118, pp.1645-1656, 2008.

Y. Iwashima, T. Horio, and M. Kumada, Adiponectin and renal function, and implication as a risk of cardiovascular disease, Am J Cardiol, vol.98, pp.1603-1608, 2006.

J. Jo, J. W. Sull, E. J. Park, and S. H. Jee, Effects of smoking and obesity on the association between CDH13 (rs3865188) and adiponectin among Korean men: the KARE study, Obesity, vol.20, pp.1683-1687, 2012.

K. Matsuda, Y. Fujishima, and N. Maeda, Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice, Endocrinology, vol.156, pp.934-946, 2015.

H. Gao, Y. Kim, and C. P. , Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations, Diabetes, vol.62, pp.4277-4283, 2013.

A. Nicolas, R. Aubert, and N. Bellili-muñoz, T-cadherin gene variants are associated with type 2 diabetes and the Fatty Liver Index in the French population, Diabetes Metab, vol.43, pp.33-39, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01346617

J. Arnemann, O. Sultani, D. Hasgün, W. Coerdt, and . T-/h-cadherin, CDH13): a new marker for differentiating podocytes, vol.448, pp.160-164, 2006.

N. Sandholm, R. M. Salem, and A. J. Mcknight, New susceptibility loci associated with kidney disease in type 1 diabetes, PLoS Genet, vol.8, p.1002921, 2012.

W. W. Williams, R. M. Salem, and A. J. Mcknight, Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy, Diabetes, vol.61, pp.2187-2194, 2012.

D. Levy, M. G. Larson, and E. J. Benjamin, Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness, BMC Med Genet, vol.8, issue.1, p.3, 2007.

X. Xu, J. J. Rogus, H. A. Terwedow, and Y. J. , An extreme-sib-pair genome scan for genes regulating blood pressure, Am J Hum Genet, vol.64, pp.1694-1701, 1999.

J. T. Bell, C. Wallace, and R. Dobson, Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension, Hum Mol Genet, vol.15, pp.1365-1374, 2006.

D. Pfaff, A. W. Schoenenberger, B. Dasen, P. Erne, T. J. Resink et al., Plasma Tcadherin negatively associates with coronary lesion severity and acute coronary syndrome, Eur Heart J Acute Cardiovasc Care, vol.4, pp.410-418, 2015.